Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Toxins|January 24, 2025
Does Clostridium Perfringens Epsilon Toxin Mimic an Auto-Antigen Involved in Multiple Sclerosis?Marie-Lise Gougeon, Valérie Seffer, Cezarela Hoxha, et al.
Multiple Sclerosis and Related Disorders|March 23, 2024
Evidence of disease activity during pregnancy and post-partum in MS patients treated with high-efficacy therapiesOussama Sahloul, Céline Louapre, Ysoline Beigneux, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|February 4, 2021
Unexpected REM sleep excess associated with a pontine lesion in multiple sclerosisSinéad Zeidan, Stefania Redolfi, Caroline Papeix, et al.
Multiple Sclerosis and Related Disorders|June 17, 2017
Fatigue evaluation in fingolimod treated patients: An observational studyMarion Masingue, Rabab Debs, Elisabeth Maillart, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 20, 2020
Relapses During High-Dose Biotin Treatment in Progressive Multiple Sclerosis: a Case-Crossover and Propensity Score-Adjusted Prospective CohortPierre Branger, Jean-Jacques Parienti, Nathalie Derache, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 27, 2023
Recurrence of severe symptomatic late-onset neutropenia on ocrelizumabYsoline Beigneux, Celine Louapre, Kevin Bihan, et al.
Frontiers in Neurology|May 23, 2017
Efficacy and Safety of Fingolimod in Daily Practice: Experience of an Academic MS French CenterThomas Roux, Elisabeth Maillart, Jean-Sébastien Vidal, et al.
Neurology|February 26, 2017
Fast multiple sclerosis progression in North Africans: Both genetics and environment matterYoussef Sidhom, Elisabeth Maillart, Sophie Tezenas du Montcel, et al.
Neurology|July 6, 2022
Pearls & Oy-sters: Spinal Cord Candidiasis Linked to CARD9 Deficiency Masquerading as a Longitudinally Extensive Transverse MyelitisLina Jeantin, Isabelle Plu, Maria Del Mar Amador, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Extensive white matter lesions after 2 years of fingolimod: Progressive multifocal leukoencephalopathy or MS relapse?Marine Boudot de la Motte, Céline Louapre, Anne Bertrand, et al.
Pageof 14